Abstract
Prior breast cryoablation studies have shown promising results for cryoablation for selected low-risk early-stage breast cancer, but many non-surgical candidates are excluded from these clinical trials due to unfavorable patient and tumor characteristics. This study aims to assess ipsilateral breast tumor recurrence (IBTR) after ultrasound (US)-guided percutaneous cryoablation in these suboptimal cryoablation candidates.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
